|
|
||||||||
1 Departments of Medicine and 2 Pediatrics and 3 Institute of Molecular Cardiobiology, Johns Hopkins University, Baltimore, Maryland 21205; and 4 Department of Cardiology and Pneumology, Georg-August-University, 37075 Göttingen, Germany
| |
ABSTRACT |
|---|
|
|
|---|
Cardiac excitation-contraction
(E-C) coupling is impaired at the myofilament level in the reversible
postischemic dysfunction known as "stunned" myocardium. We
characterized tension development and calcium cycling in intact
isolated trabeculae from transgenic (TG) mice expressing the major
proteolytic degradation fragment of troponin I (TnI) found in stunned
myocardium (TnI1-193) and determined the ATPase
activity of myofibrils extracted from TG and non-TG mouse hearts. The
phenotype of these mice at baseline recapitulates that of stunning.
Here, we address the question of whether contractile reserve is
preserved in these mice, as it is in genuine stunned myocardium. During
twitch contractions, calcium cycling was normal, whereas tension was
greatly reduced, compared with non-TG controls. A decrease in maximum
Ca2+-activated tension and Ca2+ desensitization
of the myofilaments accounted for this contractile dysfunction. The
decrease in maximum tension was paralleled by an equivalent decrease in
maximum Ca2+-activated myofibrillar ATPase activity.
Exposure to high calcium or isoproterenol recruited a sizable
contractile reserve in TG muscles, which was proportionately similar to
that in control muscles but scaled downward in amplitude. These results
suggest that calcium regulatory pathways and
-adrenergic signal
transduction remain intact in isolated trabeculae from stunned TG mice,
further recapitulating key features of genuine stunned myocardium.
cardiac excitation-contraction coupling; signal transduction; calcium ion sensitivity
| |
INTRODUCTION |
|---|
|
|
|---|
REPERFUSION AFTER BRIEF MYOCARDIAL ISCHEMIA leaves behind a sustained contractile dysfunction despite the absence of irreversible structural damage and despite complete restoration of coronary flow (5). This condition, which has been termed "stunned myocardium" (7), may persist for hours to up to several days but is, eventually, fully reversible. With the development of methods aimed at achieving prompt reperfusion in patients with acute myocardial ischemia, stunned myocardium is now recognized to be of considerable clinical relevance (4).
Intracellular Ca2+ homeostasis in stunned myocardium appears to be unimpaired (19). Depressed contractile function despite normal Ca2+ cycling is indicative of a reduced Ca2+ responsiveness of contraction, which was, indeed, shown in isolated intact trabeculae from ischemic-reperfused rat hearts (13). This pinpoints the critical lesion to the myofilaments, which translate the intracellular Ca2+ signal into force development during the distal steps of excitation-contraction (E-C) coupling. On the basis of reports showing that the activity of the Ca2+-dependent proteolytic enzyme calpain is enhanced in postischemic-reperfused myocardium (30, 31), Gao et al. (13) used an immunoblot analysis to probe myofibrillar homogenates from rat stunned myocardium for proteolysis products of a variety of myofilament proteins. The thin-filament regulatory protein troponin I (TnI) uniquely displayed a low-molecular-weight band in addition to the parent protein, indicating specific partial proteolytic degradation. The primary TnI degradation product was subsequently identified as TnI1-193, which lacks the 17 COOH-terminal residues of full-length cardiac TnI (22).
TnI in striated muscles is a key component of the ternary troponin complex, where it, in concert with the Ca2+-binding subunit troponin C (TnC) and the tropomyosin-binding subunit troponin T, Ca2+ dependently switches on and off the contractile machinery. This critical involvement in the regulation of thin-filament activation raises the possibility that proteolysis of even a small fraction of TnI may suffice to cause the contractile dysfunction typical of stunned myocardium (13). We (23) generated a transgenic (TG) animal model in which mice cardiac specifically expressed TnI1-193 at a fraction of total TnI comparable with that found in ischemic-reperfused rat hearts and reported that the myocardium of TG mice at baseline exhibits contractile dysfunction. In that initial report, the response of tension development during twitches to different Ca2+ concentrations was not investigated nor was signal transduction probed. Furthermore, precise analysis of the Ca2+ sensitivity of contraction was impaired by the low overall Ca2+ sensitivity of the intact mouse myocardium.
The present work adds to our recent study by demonstrating that, despite impaired E-C coupling, isolated intact trabeculae from TG mice maintain a contractile reserve that can be recruited by positive inotropic interventions. We also verify that, during twitches, TG mouse trabeculae exhibit both reduced Ca2+ sensitivity and Ca2+ responsiveness, thereby recapitulating key features of genuine stunned myocardium. A preliminary report has been previously published (see Ref. 18).
| |
METHODS |
|---|
|
|
|---|
Transgenic mouse model. Transgenic mice with cardiac expression of the equivalent of the major proteolytic product of TnI (TnI1-193) in stunned myocardium were produced as described (23). Transgene status was assessed by PCR from genomic DNA prepared from tail clips using a Gentra puregene kit and transgene-specific oligonucleotides. Non-TG control mice were either littermates of TG mice or were obtained from the same parental strain (C57BL/6).
Mouse intact muscle preparation.
All experimental procedures were approved by the Johns Hopkins
University Animal Care and Use Committee and were carried out essentially as described (14). Adult mice (age 3-8
mo) of either gender were euthanized by intraperitoneal injection of
pentobarbitol sodium (~7.5-15 mg), and their hearts were
excised. Intact trabeculae or thin papillary muscles were isolated from
the right ventricles and mounted in a superfusion bath between a force
transducer (type AE 801, SensoNor; Horten, Norway) and a rigid hook
connected to a micromanipulator for length adjustment. Thin unbranched
preparations that were suitable for experiments were found in ~20%
of mouse hearts. The muscles were superfused at 10 ml/min with a
modified Krebs-Henseleit solution equilibrated with 95%
O2-5% CO2, which contained (in mM): 142 Na+, 5 K+, 1.2 Mg2+, 1.0 Ca2+, 127 Cl
, 2 PO


Measurement of [Ca2+]i
using fura 2.
Fura 2 pentapotassium salt (Molecular Probes; Eugene, OR) was
microinjected iontophoretically into two to four cells and allowed to
spread evenly throughout the entire preparation via gap junctions (2). Fura 2 fluorescence was excited at 340 and 380 nm,
and the emitted light was collected at 510 nm by a photomultiplier tube
(R2693, Hamamatsu; Bridgewater, NJ). The light signal was filtered at
100 Hz, collected by an analog-to-digital converter, and stored on a
computer for later analysis. The autofluorescence of the muscle was
subtracted from the raw fluorescence data, and [Ca2+]i was calculated using the following
equation (15): [Ca2+]i = K
Rmin)/(Rmax
R), where R is the observed
fluorescence ratio (340/380 nm), K

Myofibrillar ATPase activity measurement. Myofibrils were prepared as described (24) with careful attention paid to the use of protease inhibitors. Assays were performed with the use of incubation conditions established by varying the total concentration of metals, salts, and ligands, maintaining ionic strength using the stability constants compiled by Fabiato (9), and were performed at pH 7.0 with 50 mM imidazole, 50 mM KCl, and 2 mM MgATP. Inorganic phosphate liberation was measured using a microtiter plate version of the standard assay as described by Rarick et al. (25), and the ATPase activity was calculated in nanomoles of inorganic phosphate liberated per milligram of myofibrillar protein per minute.
-Adrenergic stimulation.
l-Isoproterenol (Sigma; St. Louis, MO) was added to the
superfusate from a 1 mM stock solution in distilled H2O to
a final concentration of 300 nM.
Analytical methods.
Measured force was converted into tension by normalization with respect
to the cross-sectional area of each muscle. To characterize the
steady-state tension-[Ca2+]i relationship,
tension and [Ca2+]i data obtained from each
muscle during tetanic contractions were fitted to a Hill equation as
follows: FX
Fmin = (Fmax
Fmin)[CaX]


| |
RESULTS |
|---|
|
|
|---|
Effect of
[Ca2+]o on
Ca2+ transients and twitch
tension.
We simultaneously examined Ca2+ cycling and tension
development during twitches of TG and non-TG mouse intact right
ventricular trabeculae at various [Ca2+]o. We
carried out the experiments in a blinded fashion such that the
investigator did not know the group identity of a mouse until after
analysis of the data. Figure 1 shows the
time course of [Ca2+]i and tension of
representative non-TG and TG TnI1-193 preparations at
2.0 and 3.0 mM [Ca2+]o. The
[Ca2+]i transients were very similar, whereas
twitch tension was greatly reduced in the TG preparation. Considering
the generally low responsiveness of the isolated intact mouse
myocardium to external Ca2+ (14), we explored
whether this contractile dysfunction can be overcome by high
[Ca2+]o or is preserved over a broader range
of inotropic intervention by raising [Ca2+]o
incrementally from 1.0 to 6.0 mM. This intervention resulted in a
stepwise increase in peak systolic [Ca2+]i in
the non-TG control group with a quasilinear relationship (Fig.
2A), whereas diastolic
[Ca2+]i remained unaltered, indicating that
diastolic Ca2+ overload did not occur. The elevation in
peak [Ca2+]i was paralleled by an increase in
developed twitch tension (i.e., peak systolic tension minus resting
tension) from 2.8 ± 1.5 to 40.3 ± 5.8 mN/mm2 at
1.0 and 6.0 mM [Ca2+]o, respectively
(n = 6; Fig. 2B).
|
|
Characterization of the
tension-[Ca2+]i
relationship.
We measured isometric tension and [Ca2+]i
during the plateau phase of tetani elicited by 10-Hz stimulation in the
presence of ryanodine to characterize the steady-state
tension-[Ca2+]i relationship (Fig.
3, A and B; data
partially included in Ref. 23). Non-TG control muscles
attained a substantially higher maximum Ca2+-activated
tension than TG muscles (48.14 ± 7.23, n = 5, vs.
28.70 ± 0.88 mN/mm2, n = 4, P = 0.0036). Resting tensions and Hill coefficients
were similar in both groups. From Fig. 3B, which illustrates
the normalized tension-[Ca2+]i relationships,
it is obvious that the midpoint of the relation was shifted toward
higher [Ca2+]i in TG muscles by ~340 nM,
but this effect was not significant. However, a problematic feature of
these steady-state tension-[Ca2+]i
relationships is the low Ca2+ sensitivity of mouse intact
preparations compared, e.g., with the rat myocardium. The
Ca50 for isometric tension falls in a range
(~1.3-1.6 µM) that is relatively far off the
Kd of fura 2 for Ca2+ (224 nM; see
Ref. 15) such that subtle changes in fluorescence properties reflect large differences in [Ca2+].
Therefore, to obtain a more accurate estimate for the Ca2+
sensitivity of the preparations, we analyzed the relationship of
tension and [Ca2+]i during the relaxation
phase of regular twitches. In Fig. 4, A and B, developed tension is plotted versus
[Ca2+]i during twitches at three different
[Ca2+]o for representative non-TG and
TG1-193 muscles (phase-plane loops). The descending
limb of these loops, due to the phase lag between
[Ca2+]i and tension, is shifted toward lower
[Ca2+]i compared with the steady-state
tension-[Ca2+]i relationship of the same
muscle (1) and therefore falls in a range of
[Ca2+]i that is more accurately reflected by
the fura 2 fluorescence properties. In TG TnI1-193
muscles, half-maximal tension during relaxation was attained at
significantly higher [Ca2+]i than in non-TG
control muscles (0.53 ± 0.04 vs. 0.42 ± 0.03 µM,
respectively, P = 0.035; Fig. 4C),
indicating reduced Ca2+ sensitivity.
|
|
Myofibrillar ATPase activity.
We measured the ATPase activity of myofibrils extracted from non-TG
control and TG TnI1-193 mouse hearts (Fig.
5). The Ca2+-independent
basal myofibrillar ATPase activity was similar in both groups. Non-TG
control myofibrils exhibited a maximum Ca2+-activated
ATPase activity of 193 ± 9 nmol · mg
1 · min
1
(n = 8). In TG myofibrils, this ATPase activity was
reduced by 38% to 119 ± 5 nmol · mg
1 · min
1
(n = 7, P = 0.002). This reduction
closely corresponds to the 40% lower maximum
Ca2+-activated tension observed in intact muscle
preparations.
|
Inotropic response to
-adrenergic receptor stimulation.
A typical feature of stunned myocardium is its maintained contractile
reserve when stimulated with positive inotropic agents, e.g.,
catecholamines (3, 8). We therefore treated non-TG control
and TG muscles with 300 nM l-isoproterenol to examine whether this property is preserved in mouse muscles expressing TnI1-193. In non-TG control muscles, isoproterenol
induced a clear positive inotropic response: developed twitch tension at [Ca2+]o of 1.0, 2.0, and 3.0 mM was
markedly and significantly increased 15-, 6-, and 3.2-fold,
respectively, compared with twitch contractions at the same
[Ca2+]o in the absence of isoproterenol (Fig.
6B). At 3.0 mM
[Ca2+]o in the presence of isoproterenol,
twitch tension approached a maximal level (56.66 ± 18.16 mN/mm2), which was not significantly different from either
maximum Ca2+-activated tension in tetanic contractions or
the greatest twitch tension attained at 6.0 mM
[Ca2+]o in the absence of isoproterenol
(48.11 ± 7.23 and 44.48 ± 6.44 mN/mm2,
respectively). Increasing [Ca2+]o to values
>3.0 mM in the presence of isoproterenol invariably caused diastolic
Ca2+ overload and irregular spontaneous contractions. The
elevation of twitch tension was associated with a pronounced increase
in peak systolic [Ca2+]i (Fig.
6A), consistent with the known pharmacological property of
-adrenergic receptor agonists to exert their positive inotropic action by increasing calcium availability.
|
Kinetic effects of isoproterenol on twitch tension and
Ca2+ transients.
We compared twitch contractions at 3.0 mM
[Ca2+]o before and after
-adrenergic
receptor stimulation. Figure 6, A and B
(insets), shows normalized records of
[Ca2+]i and tension versus time from
representative muscles in each group in the absence and presence of
isoproterenol. Isoproterenol exerted a similar lusitropic action in
both non-TG control and TG muscles (Table
1). The time to peak systolic
[Ca2+]i was not significantly altered. In
contrast, the time from peak to half-decay of
[Ca2+]i, the time to peak tension, and the
time from peak tension to half relaxation were significantly reduced by
isoproterenol in both groups to a similar extent.
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study extends our previous findings (23)
in several major ways. Here, we show that intracellular
Ca2+ transients, sampled over a wide range of
[Ca2+]o, are indistinguishable in trabeculae
from TG mouse hearts and control muscles, consistent with unimpaired
Ca2+ cycling. In marked contrast, twitch tension in TG
muscles is greatly decreased, indicating uncoupling of excitation and
contraction. The contractile dysfunction in TG
TnI1-193 preparations is due to both a reduced overall
tension-generating capacity of TG muscles, reflected by the lower
maximum Ca2+-activated tension (which is paralleled by an
equivalent reduction in maximum Ca2+-activated myofibrillar
ATPase activity), and a decrease in Ca2+ sensitivity,
reflected by the increase in Ca50 during the relaxation phase of twitches. The proportionately similar inotropic responses to
increases in [Ca2+]o and to isoproterenol
reveal that muscles from both groups have a sizable contractile reserve
that can be recruited by positive inotropic intervention and that the
-adrenergic signaling cascade is intact. In both the TG
TnI1-193 and non-TG control myocardium, the maximum
twitch tension attainable is limited by the maximum Ca2+-activated tension, as found in tetanic contractions at
saturating [Ca2+]o.
These features closely recapitulate the functional characteristics
found in isolated trabeculae from rat hearts subjected to 20-min
ischemia/20-min reperfusion (12) and also
reproduce a well-established property of stunned myocardium in that the contractile dysfunction can partially be overcome by stimulation with
positive inotropic agents (3, 8). This phenotype also finds its equivalent in the more physiological model of regional low-flow ischemia-reperfusion in pigs, where likewise maximum calcium-stimulated contractility was greatly impaired, whereas a
reduction in calcium sensitivity appeared to be less prominent (16). Therefore, the presence of even a low amount of
TnI1-193 in the absence of any additional damage
suffices to produce the defective E-C coupling with a maintained
-adrenergic signaling cascade typical of stunning. These findings,
as well as the impairment in hemodynamic function in these mice in vivo
(23), strongly support the putative causal role of TnI
degradation in the pathogenesis of myocardial stunning. Moreover,
because in this TG mouse model the TnI fragment 1-193 is generated
independent of proteolysis of the parent protein, the 17-residue
COOH-terminal fragment formed as a byproduct of TnI proteolysis in
genuine stunned myocardium is not necessary to induce the "stunned" phenotype.
In this and also our previous study (23), the comparative analysis of the steady-state tension-[Ca2+]i relationships did not allow us to make a conclusive statement about differences in the Ca2+ sensitivity of TG TnI1-193 and non-TG control preparations. This was due to the generally low Ca2+ sensitivity of tension observed in the mouse intact myocardium (14) in which Ca50 values fall in a range where [Ca2+]i calculated from fura 2 fluorescence data shows considerable dispersion. Because of this inaccuracy, to confirm a statistically significant difference of Ca50 values between groups would require experimental numbers that are both impractical and ethically questionable to achieve, given the low frequency of suitable preparations in mouse hearts and considering that reliable information on the Ca2+ sensitivity can be extracted from twitch data using the alternative method we established here. During the relaxation phase of a twitch, myofilament activation (i.e., tension) and [Ca2+]i exhibit a sigmoidal relationship. Because of the phase lag between [Ca2+]i and tension during a twitch, this relationship is shifted toward lower [Ca2+]i compared with steady-state conditions during tetani elicited in the presence of ryanodine, to a range in which fura 2 fluorescence properties allow for calculation of [Ca2+]i with greater accuracy. In the twitch tension-[Ca2+]i plots (phase-plane "loops"), a Hill equation can be fitted to the descending limb and a Ca50 value can be calculated that represents the [Ca2+]i at which active tension has declined to 50% of the peak value.
To calculate Ca50 from the steady-state tension-[Ca2+]i relationship is an accepted procedure to analyze the Ca2+ sensitivity of intact cardiac preparations, because during the plateau of tetanic contractions a well-characterized and highly reproducible equilibrium exists between [Ca2+]i and the level of myofilament activation. This equilibrium, however, is generated under unphysiological conditions involving 10-Hz stimulation and disruption of sarcoplasmic reticulum function using ryanodine. In contrast, the experimental conditions during twitches are more physiological. The leftward shift of the descending limb compared with the steady-state tension-[Ca2+]i relationship indicates that relaxation in cardiac muscle is not limited by the decay rate of the [Ca2+]i transient but rather by the myofilaments themselves (1). Thus the Ca50 value calculated from twitch relaxation truly represents properties intrinsic to the myofilaments and therefore can be used to compare the Ca2+ sensitivities of different groups. It is clear, however, that Ca50 values calculated from twitch relaxation data must not be compared with Ca50 values calculated from steady-state data. Because of damaged-end compliance (28) and the length dependence of Ca2+ sensitivity, sarcomere shortening in the central part of the preparation may theoretically decrease the overall Ca2+ sensitivity of a preparation. Additionally, central sarcomere shortening has been observed to result in an increase of the peak of the Ca2+ transient (17). Both these effects would be expected to be more pronounced in the group of preparations contracting more strongly, i.e., in non-TG control muscles. If anything, this effect will tend to underestimate the difference in Ca2+ sensitivity between control and TG preparations, as detected in this study, and therefore does not affect the conclusions drawn regarding the effect of TnI1-193 expression on Ca2+ sensitivity.
In our previous study (23), impedance catheter
measurements revealed that
-adrenergic receptor stimulation
increased the maximal rate of pressure development
(dP/dtmax) in both TG and non-TG mice.
The maximal rate of decay of pressure
(dP/dtmin), however, was not affected in
vivo by isoproterenol treatment (23). If the
-adrenergic pathway is intact, cAMP-dependent phosphorylation of
phospholamban and TnI is expected to accelerate relaxation in cardiac
muscle. We therefore analyzed the effects of isoproterenol on the
kinetics of tension and [Ca2+]i transient
during twitches of trabeculae isolated from their environment. Our data
confirm that, in isolated muscle preparations from both TG
TnI1-193 and non-TG control mice, isoproterenol treatment significantly enhanced the speed of contraction and relaxation, consistent with the
-adrenergic cascade being intact in
our transgenic model. The lack of effect of isoproterenol on
dP/dtmin in vivo may be explained by prior
sympathetic activation due to anesthesia of the animals or by
additional effects on the systemic vascular resistance, which can be
excluded in the isolated cardiac muscle preparation.
The mechanism by which TnI1-193 impairs contractility is unknown. Degradation of a certain amount of intact TnI could result in partial "loss of function" of the full-length protein. Alternatively, a "gain of function" of the degraded form of TnI could occur, exposing regulatory properties different from those of the parent protein. A complete loss of function of a fraction of TnI most likely would result in failure of the myocardium to relax fully, analogous to myocardium from which TnI has been partially extracted, e.g., using vanadate (27). This is not likely to be the case in TG preparations, because we did not observe any elevation in resting tension. The concept of altered regulatory properties of the deletion mutant is supported by Rarick et al. (26), who demonstrated that recombinant cTnI1-188, which is missing only six more residues than the transgenically generated cTnI1-193 fragment used in our study, displayed impaired ability to fully inhibit myofibrillar ATPase activity in the absence of Ca2+ and to fully activate myofibrillar ATPase activity at saturating [Ca2+], whereas cTnI1-199 behaved essentially as the wild-type protein. A recent study (10) mapping cardiac TnI-TnC interactions with synthetic peptides identified an interaction between TnI191-210 and TnC (10). Furthermore, two point mutations located within this region, Gly203Ser and Lys206Gln, are associated with familial hypertrophic cardiomyopathy (6), underlining the possible functional relevance of loss of this segment. Whether or not the regulatory properties of TnI1-193 are qualitatively or quantitatively different from those of the parent protein cannot be resolved on intact isolated muscle preparations of this TG mouse model. Our observation that maximum Ca2+-activated myofibrillar ATPase activity in TG preparations is reduced to a similar extent as maximum Ca2+-activated tension in intact trabeculae indicates that the effect of TnI truncation on actomyosin interaction does not depend on the strain on the cross-bridges, because a suspension of myofibrils in solution bears no load. Further studies involving the biochemical characterization of purified recombinant troponin subunits are required to clarify this point.
An important question remains as to whether TnI degradation is necessary for the development of stunning, because several studies (21, 29) in larger animal models failed to demonstrate TnI degradation in stunned myocardium. It has, however, been pointed out that to reliably exclude the presence of TnI degradation products by Western blot analysis requires probing of tissue samples with a variety of antibodies directed against different epitopes on TnI (11), and, importantly, TnI degradation has been observed in myocardial biopsies of human ischemic heart disease patients (23).
In summary, we present evidence confirming that
TnI1-193 is capable of producing the stunned phenotype
in the absence of any additional ischemia-reperfusion-induced
damage, supporting the hypothesis that stunning is caused by
proteolytic degradation of TnI. The preservation of upstream inotropic
responsiveness implies that calcium and
-adrenergic signaling remain
intact in the TG mice, as they do in genuine stunned myocardium.
| |
ACKNOWLEDGEMENTS |
|---|
We thank J. Robinson for technical assistance and P. M. L. Janssen for help with analyzing the ATPase data.
| |
FOOTNOTES |
|---|
This work was supported by Deutsche Forschungsgemeinschaft Grant KO 1873/1-1 (to H. Kögler), National Heart, Lung, and Blood Institute Grants F32 HL-10401 (to D. G. Soergel), R01 HL-63038 (to A. M. Murphy), and R01 HL-44065 (to E. Marbán), an American Heart Association grant-in-aid (to A. M. Murphy), and by the Michel Mirowski M.D. Professorship of Cardiology (to E. Marbán).
Address for reprint requests and other correspondence: E. Marbán, Institute of Molecular Cardiobiology, Johns Hopkins Univ., 844 Ross Bldg., 720 Rutland Ave., Baltimore, MD 21205 (E-mail: marban{at}jhmi.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 6 November 2000; accepted in final form 31 January 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Backx, PH,
Gao WD,
Azan-Backx MD,
and
Marbán E.
The relationship between contractile force and intracellular [Ca2+] in intact rat cardiac trabeculae.
J Gen Physiol
105:
1-19,
1995
2.
Backx, PH,
and
Ter Keurs HEDJ
Fluorescent properties of rat cardiac trabeculae microinjected with fura 2 salt.
Am J Physiol Heart Circ Physiol
264:
H1098-H1110,
1993
3.
Becker, LC,
Levine JH,
DiPaula AF,
Guarnieri T,
and
Aversano T.
Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation.
J Am Coll Cardiol
7:
580-589,
1986[Abstract].
4.
Bolli, R.
Myocardial "stunning" in man.
Circulation
86:
1671-1691,
1992
5.
Bolli, R,
and
Marbán E.
Molecular and cellular mechanisms of myocardial stunning.
Physiol Rev
79:
609-634,
1999
6.
Bonne, G,
Carrier L,
Richard P,
Hainque B,
and
Schwartz K.
Familial hypertrophic cardiomyopathy.
Circ Res
83:
580-593,
1998
7.
Braunwald, E,
and
Kloner RA.
The stunned myocardium: prolonged, postischemic ventricular dysfunction.
Circulation
66:
1146-1149,
1982
8.
Ellis, SG,
Wynne J,
Braunwald E,
Henschke CI,
Sandor T,
and
Kloner RA.
Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation.
Am Heart J
107:
13-19,
1984[Web of Science][Medline].
9.
Fabiato, A.
Myoplasmic free calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle.
J Gen Physiol
78:
457-497,
1981
10.
Ferrières, G,
Pugnière M,
Mani JC,
Villard S,
Laprade M,
Doutre P,
Pau B,
and
Granier C.
Systemic mapping of regions of human cardiac troponin I involved in binding to cardiac troponin C: N- and C-terminal low affinity contributing regions.
FEBS Lett
479:
99-105,
2000[Web of Science][Medline].
11.
Foster, DB,
and
Van Eyk JE.
In search of the proteins that cause myocardial stunning.
Circ Res
85:
470-472,
1999
12.
Gao, WD,
Atar D,
Backx PH,
and
Marbán E.
Relationship between intracellular calcium and contractile force in stunned myocardium.
Circ Res
76:
1036-1048,
1995
13.
Gao, WD,
Atar D,
Liu Y,
Pérez NG,
Murphy AM,
and
Marbán E.
Role of troponin I proteolysis in the pathogenesis of stunned myocardium.
Circ Res
80:
393-399,
1997.
14.
Gao, WD,
Pérez NG,
and
Marbán E.
Calcium cycling and contractile activation in intact mouse cardiac muscle.
J Physiol
507:
175-184,
1998
15.
Grynkiewicz, G,
Poenie M,
and
Tsien TY.
A new generation of Ca2+ indicators with greatly improved fluorescent properties.
J Biol Chem
260:
3440-3450,
1985
16.
Heusch, G,
Rose J,
Skyschally A,
Post H,
and
Schulz R.
Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart.
Circulation
93:
1556-1566,
1996
17.
Janssen, PML,
and
de Tombe PP.
Uncontrolled sarcomere length shortening increases the intracellular Ca2+ transient in rat cardiac trabeculae.
Am J Physiol Heart Circ Physiol
272:
H1892-H1897,
1997
18.
Kögler, H,
Murphy AM,
and
Marbán E.
Excitation-contraction coupling in a transgenic mouse model of stunned myocardium (Abstract).
Circulation
100, SupplI:
I-766,
1999.
19.
Kusuoka, H,
Koretsune Y,
Chacko VP,
Weisfeldt ML,
and
Marbán E.
Excitation-contraction coupling in postischemic myocardium: does failure of activator Ca2+ transients underlie stunning?
Circ Res
66:
1268-1276,
1990
20.
Layland, J,
and
Kentish JC.
Positive force- and [Ca2+]i-frequency relationships in rat ventricular trabeculae at physiological frequencies.
Am J Physiol Heart Circ Physiol
276:
H9-H18,
1999
21.
Matejovicova, M,
Kaplan P,
Mubagwa K,
Raeymaekers L,
Pongo E,
and
Flameng W.
Phosphorylation by protein kinases A and C of myofibrillar proteins in rabbit stunned and non-stunned myocardium.
J Mol Cell Cardiol
29:
3189-3202,
1997[Web of Science][Medline].
22.
McDonough, JL,
Arrell DK,
and
Van Eyk JE.
Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury.
Circ Res
84:
9-20,
1999
23.
Murphy, AM,
Kögler H,
Georgakopoulos D,
McDonough JL,
Kass DA,
Van Eyk JE,
and
Marbán E.
Transgenic mouse model of stunned myocardium.
Science
287:
488-491,
2000
24.
Murphy, AM,
and
Solaro RJ.
Developmental difference in the stimulation of cardiac myofibrillar Mg2(+)-ATPase activity by calmidazolium.
Pediatr Res
28:
46-49,
1990[Web of Science][Medline].
25.
Rarick, HM,
Opgenorth TJ,
von Geldern TW,
Wu-Wong JR,
and
Solaro RJ.
An essential myosin light chain peptide induces supramaximal stimulation of cardiac myofibrillar ATPase activity.
J Biol Chem
271:
27039-27043,
1996
26.
Rarick HM, Tu XH, Solaro RJ, and Martin AF. The C terminus of
cardiac troponin I is essential for full inhibitory activity and
Ca2+ sensitivity of rat myofibrils. J Biol Chem
272: 26887-26892.
27.
Strauss, JD,
Zeugner C,
Van Eyk JE,
Bletz C,
Troschka M,
and
Rüegg JC.
Troponin replacement in permeabilized cardiac muscle. Reversible extraction of troponin I by incubation with vanadate.
FEBS Lett
310:
229-234,
1992[Web of Science][Medline].
28.
Ter Keurs, HEDJ,
Rijnsburger WH,
van Heuningen R,
and
Nagelsmit MJ.
Tension development and sarcomere length in rat cardiac trabeculae: evidence of length-dependent activation.
Circ Res
46:
703-714,
1980
29.
Thomas, SA,
Fallavollita JA,
Lee TC,
Feng J,
and
Canty FM.
Absence of troponin I degradation or altered sarcoplasmic reticulum uptake protein expression after reversible ischemia in swine.
Circ Res
85:
446-456,
1999
30.
Yoshida, K,
Inui M,
Harada K,
Saido TC,
Sorimachi Y,
Ishihara T,
Kawashima S,
and
Sobue K.
Reperfusion of rat heart after brief ischemia induces proteolysis of calspectrin (non-erythroid spectrin or fodrin) by calpain.
Circ Res
77:
603-610,
1995
31.
Yoshida, K,
Yamasaki Y,
and
Kawashima S.
Calpain activity alters in rat myocardial subfractions after ischemia or reperfusion.
Biochim Biophys Acta
1182:
215-220,
1993[Medline].
This article has been cited by other articles:
![]() |
J. Liu, J. Du, C. Zhang, J. W. Walker, and X. Huang Progressive troponin I loss impairs cardiac relaxation and causes heart failure in mice Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1273 - H1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Bilchick, J. G. Duncan, R. Ravi, E. Takimoto, H. C. Champion, W. D. Gao, L. B. Stull, D. A. Kass, and A. M. Murphy Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H318 - H325. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Sirenko, J. D. Potter, and B. C. Knollmann Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts - role of myofilament Ca2+ sensitivity increase J. Physiol., August 15, 2006; 575(1): 201 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Varian, S. Raman, and P. M. L. Janssen Measurement of myofilament calcium sensitivity at physiological temperature in intact cardiac trabeculae Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2092 - H2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Chen and O. Ogut Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin Am J Physiol Cell Physiol, March 1, 2006; 290(3): C719 - C727. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Duncan, R. Ravi, L. B. Stull, and A. M. Murphy Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1512 - H1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Stull, M. K. Leppo, L. Szweda, W. D. Gao, and E. Marban Chronic Treatment With Allopurinol Boosts Survival and Cardiac Contractility in Murine Postischemic Cardiomyopathy Circ. Res., November 12, 2004; 95(10): 1005 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Soergel, D. Georgakopoulos, L. B. Stull, D. A. Kass, and A. M. Murphy Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1785 - H1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Foster, T. Noguchi, P. VanBuren, A. M. Murphy, and J. E. Van Eyk C-Terminal Truncation of Cardiac Troponin I Causes Divergent Effects on ATPase and Force: Implications for the Pathophysiology of Myocardial Stunning Circ. Res., November 14, 2003; 93(10): 917 - 924. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |